Mazurczak Karolina, Pańkowska Ewa, Ładyżyński Piotr, Foltyński Piotr
1 Institute of Diabetology, Warsaw, Poland.
2 Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Science, Warsaw, Poland.
J Diabetes Sci Technol. 2017 Jan;11(1):7-11. doi: 10.1177/1932296816683963. Epub 2016 Dec 20.
The insulin therapy in type 1 diabetes involves a wide array of restrictions in patients and their families. One of those is a difficulty in estimation of the insulin dose programmed for each meal. The purpose of the study is an assessment of functionalities related to the expert system VoiceDiab-a calculator of meal boluses.
The sample group composed of 54 patients, aged 3-52, all suffering from type 1 diabetes, treated with the insulin pump, taking part in the clinics RCT (for adults and a pediatrician), with a randomized allocation to a surveyed group and cross-over. The research methodology was based upon questionnaires and open-ended questions.
40% of respondents recognized the application's usefulness as high (18 of 47), giving it 10 points, and easy to use (70%). Disadvantages of this app comprised lack of some products in the application database (n = 23), troubles with the mobile range ( n = 4), and no option of a manual data input for processing purposes (n = 23). Advantages, that have been mentioned the most frequently included facilitation of measurements (n = 7), enhanced life quality of the patient (n = 8), and a guarantee of prompt and thorough calculations (n = 22). Of the surveyed individuals, 50% reached their diet, while 100% gave a top grade to the application, claiming it had contributed to a more efficient metabolic control.
The pilot scheme of the expert system VoiceDiab has potential to become an application, facilitating dosing of the meal insulin and improving the comfort and safety of insulin administering. However, it needs to be modified, as mentioned by the users who have tested the system.
1型糖尿病的胰岛素治疗给患者及其家庭带来了诸多限制。其中之一是难以估算每餐设定的胰岛素剂量。本研究的目的是评估与专家系统VoiceDiab(一种餐时大剂量胰岛素计算器)相关的功能。
样本组由54名年龄在3至52岁之间、均患有1型糖尿病且使用胰岛素泵治疗的患者组成,他们参与了临床随机对照试验(针对成人和儿科医生),被随机分配到调查小组并进行交叉试验。研究方法基于问卷和开放式问题。
40%的受访者认为该应用非常有用(47人中有18人),给予其10分,且易于使用(70%)。该应用的缺点包括应用数据库中缺少一些产品信息(n = 23)、移动信号范围问题(n = 4)以及没有手动数据输入以供处理的选项(n = 23)。最常被提及的优点包括测量方便(n = 7)、提高患者生活质量(n = 8)以及保证快速准确的计算(n = 22)。在接受调查的个体中,50%达到了饮食目标,100%对该应用给予了高度评价,称其有助于更有效的代谢控制。
专家系统VoiceDiab的试点方案有潜力成为一款应用程序,有助于餐时胰岛素给药,提高胰岛素注射的舒适度和安全性。然而,正如测试该系统的用户所提到的,它需要进行改进。